Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gap Inc V.GAP


Primary Symbol: GAP

The Gap, Inc. is a specialty apparel company in America. The Company offers apparel, accessories and personal care products for women, men and children. Its Old Navy, Gap, Banana Republic, and Athleta brands offer clothing, accessories and lifestyle products for men, women and children. It is an omni-channel retailer, with sales to customers both in stores and online, through Company-operated and franchise stores, websites, and third-party arrangements. Its omni-channel services, including buying online pick-up in store, order-in-store, find-in-store, and ship-from-store, as well as enhanced mobile-enabled experiences, are tailored across its collection of brands. Gap includes adult apparel and accessories, GapKids, babyGap, Gap Maternity, GapBody, and GapFit collections. Banana Republic is a premium lifestyle retailer celebrating exploration and self-expression through timeless quality, versatile fabrics, and exceptionally made womenswear, menswear, and home designs.


NYSE:GAP - Post by User

Comment by Rugger1on Oct 05, 2010 1:40pm
465 Views
Post# 17530721

RE: Mice?

RE: Mice?It is true that most of the testing has been convered in the past but from what I remember in your past posts is that the compound was changed or redesigned into the newest for it is now base on problems with the previous compound.  With that in mind it was pretty much a square one deal with having to go thru the testings again.  I do see in my notes of the conference call talk about testing in other animal analoges but I didn't write down dogs specifically so cannot back you up on that comment by either Dr. Sokoll or Mr McInnis.    The company drug development is in Dr. Sokoll's direction since September 1st and the impression I got was he was almost given a carte blanche to the testings going forward based on his experiences.  Delays in results are the norm here and likely Kayday we will be talking about this till the eventual day they release the news they are into IND applications sometime in the future (hopefully in our lifetime)

Also anyone have problems with getting on the Lab Research website today?  I seem to get a different company when I try to get to the site. 
<< Previous
Bullboard Posts
Next >>